Hormonal Contraceptive Use and History of Sexually Transmitted Infection as Risk Factors of the Pre‑Cancerous Cervical Lesions
DOI:
https://doi.org/10.53638/phpma.2015.v3.i2.p09Keywords:
pre-cancerous cervical lesions, hormonal contraceptives, STI historyAbstract
Background and purpose: Screening for pre-cancerous cervical lesions is already being implemented in Bali. This study aims to determine hormonal contraceptives and STI history as risk factors of pre-cancerous cervical lesions.
Methods: A case-control study was conducted involving 76 women of childbearing age diagnosed with pre-cancerous cervical lesions who screened at two health centers in Denpasar Bali from January to March 2015. Control was 76 women of childbearing age with no pre-cancerous cervical lesions who screened at the same period. Consecutive sampling was used to select cases and controls. Data were collected through interview using questionnaires and analyzed using logistic regression to calculate adjusted odd ratio of each risk factor.
Results: Multivariate analysis indicated that the use of hormonal contraceptives over ≥5 or <5 years increase risk of pre-cancerous cervical lesions with OR=10,7 (95%CI: 1,04-108,17) and OR=3,0 (95%CI: 1,16-7,84) compared to those who were not using hormonal contraception. History of sexually transmitted infections also increases risk of pre-cancerous cervical lesions with OR=9,7 (95%CI: 3,83 24,18).
Conclusion: The use of hormonal contraceptives and history of sexual transmitted infections increased risks of pre-cancerous cervical lesions.
References
WHO/ICO. Comprehensive Cervical Cancer Prevention and Control a Healthier Future for Girls and Women: Summary Report update 2013.WHO; 2013.
Departemen Kesehatan RI. Skrining Kanker Leher Rahim Dengan Metode IVA. Jakarta: Depkes RI; 2008.
Dinas Kesehatan Provinsi Bali. Profil Kesehatan Provinsi Bali Tahun 2013. Denpasar: Dinas Kesehatan Provinsi Bali; 2014
Suwiyoga, IK. Beberapa Masalah Pap Smear sebagai Alat Diagnosis Dini Kanker Serviks Di Indonesia. Jurnal Studi Jender Srikandi. 2010 (diakses 14 Juli 2014). Available from URL: http:ojs.unud.ac.id/index.php/srikandi/article/view/2755.
Andrijono. Kanker Serviks. Jakarta: Divisi Onkologi Departemen Obstetri Ginekologi Fakultas Kedokteran Universitas Indonesia; 2009.
Rasjidi. Manual Prakanker Serviks. Jakarta: Sagung Seto; 2008.
Delia, W. Pembunuh Ganas itu Bernama Kanker Servik. Yogyakarta: Kejora; 2010.
Andrijono. Sinopsis Kanker Ginekologi. Jakarta: Divisi Onkologi Departemen Obstetri Ginekologi, Fakultas Kedokteran Universitas Indonesia; 2013.
Dinas Kesehatan Kota Denpasar. Profil Kesehatan Kota Denpasar Tahun 2013. Denpasar: Dinas Kesehatan Kota Denpasar; 2014.
Departemen Kesehatan RI. Skrining Kanker Leher Rahim dengan Metode IVA. Jakarta: Depkes RI; 2008.
Triwahuningsih. Faktor Risiko yang Berhubungan dengan Kejadian Lesi Prakanker Leher Rahim dengan Metode IVA di Puskesmas Jatinegara (tesi). Jakarta: Universitas Esa Unggul; 2013.
Suriani. Faktor Risiko Lesi Prakanker Leher Rahim pada PUS di Kecamatan Payangan Gianyar (tesis. Denpasar: Universitas Udayana; 2011.
Rusmana. Aspek Onkologi Human Papillomavirus. Fakultas Kedokteran, Universitas Kristen Maranatha, JKM 2009;9.
Harahap. Neoplasia Intraepitel pada Kanker Serviks (NIS), Pendekatan Ilmiah Pencegahan Kanker Leher Rahim. Jakarta: UI Press; 2006.
Melva. Faktor-faktor yang Mempengaruhi Kejadian Kanker Leher Rahim di RSUP Adam Malik (tesis). Sumatera Utara: Universitas Sumatera Utara; 2008.
Carol, Jones, et al. Risk Factors for Insitu Cervical Cancer: Results from a Case-Control Study Cancerres. AACR Journals.org. 2005 (cited 2014 August 14). Available from URL: http://cancerres.Aacrjournals.Orgsite/misc/terms.xhtml.
Kharsany, Hoosen. The Association Between Sexually Transmitted Pathogens and Cervical Intra-epithelial Neoplasia in a Developing Community. Genitourin Med 2002;69:35.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ni Made Parwati, I Wayan Gede Artawan Eka Putra, I Nyoman Mangku Karmaya
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
**Creative Commons Attribution 4.0 International License (CC BY 4.0)**
*Welcome to the world of open collaboration and shared creativity! The Creative Commons Attribution 4.0 International License (CC BY 4.0) empowers creators to share their work with the world while maintaining certain rights.*
**Key Points:**
1. **Freedom to Share:** CC BY 4.0 allows creators to share their work globally, granting others the freedom to use, remix, and build upon it.
2. **Attribution Requirement:** Users can use the work for any purpose, even commercially, as long as they provide appropriate credit to the original creator.
3. **Flexibility:** Applicable to various content types—text, images, music, videos—the license fosters a diverse range of creations.
**Common Use Cases:**
- **Education:** Widely used for educational materials, promoting open learning environments.
- **Research:** Applied to scholarly articles, accelerating the dissemination of knowledge.
**How to Use:**
1. **Share:** Share your work with the world, marking it with the CC BY 4.0 license.
2. **Attribution:** Users, when utilizing the work, must provide proper attribution to honor the original creator.
**Conclusion:**
CC BY 4.0 contributes to a more open and collaborative digital landscape. Join the movement of shared knowledge and creativity!
*For full license details, visit [Creative Commons](https://creativecommons.org/licenses/by/4.0/).*
